Related references
Note: Only part of the references are listed.Genistein Suppresses v-Src-Driven Proliferative Activity by Arresting the Cell-Cycle at G2/M through Increasing p21 Level in Src-Activated Human Gallbladder Carcinoma cells
Misaki Ono et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2021)
STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis
Wei-Hsin Lin et al.
ONCOGENE (2021)
The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer
J. Nathaniel Diehl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Recent Updates on Marine Cancer-Preventive Compounds
Sergey A. Dyshlovoy
MARINE DRUGS (2021)
STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications
Isidora Tosic et al.
NEOPLASIA (2021)
Targeting Akt in cancer for precision therapy
Hui Hua et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Novel Marine Secondary Metabolites Worthy of Development as Anticancer Agents: A Review
Florence Nwakaego Mbaoji et al.
MOLECULES (2021)
Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature
Sarah Peisl et al.
PLOS ONE (2021)
Pancreatic cancer: A review of epidemiology, trend, and risk factors
Jian-Xiong Hu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Targeting PI3K Pathway in Pancreatic Ductal Adenocarcinoma: Rationale and Progress
Siddharth Mehra et al.
CANCERS (2021)
Targeting STAT3 Signaling Pathway in Colorectal Cancer
Antonios N. Gargalionis et al.
BIOMEDICINES (2021)
1,2,4-Oxadiazole Topsentin Analogs with Antiproliferative Activity against Pancreatic Cancer Cells, Targeting GSK3β Kinase
Daniela Carbone et al.
CHEMMEDCHEM (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer
Yulei Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Overview of the STAT-3 signaling pathway in cancer and the development of specific inhibitors
Yuchen Gu et al.
ONCOLOGY LETTERS (2020)
Multidisciplinary consensus statement on the clinical management of patients with pancreatic cancer
E. Martin-Perez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Adjuvant chemotherapy in pancreatic cancer: state of the art and future perspectives
Leo Mas et al.
CURRENT OPINION IN ONCOLOGY (2020)
STAT3: Versatile Functions in Non-Small Cell Lung Cancer
Julian Mohrherr et al.
CANCERS (2020)
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
Uddalak Bharadwaj et al.
PHARMACOLOGICAL REVIEWS (2020)
Emerging roles for the IL-6 family of cytokines in pancreatic cancer
Gemma van Duijneveldt et al.
CLINICAL SCIENCE (2020)
PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
Rui Liu et al.
CELL DEATH & DISEASE (2020)
A systematic assessment of statistics, risk factors, and underlying features involved in pancreatic cancer
Imlimaong Aier et al.
CANCER EPIDEMIOLOGY (2019)
Mitotic CDK Promotes Replisome Disassembly, Fork Breakage, and Complex DNA Rearrangements
Lin Deng et al.
MOLECULAR CELL (2019)
Long-Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair Analysis
Pauline Rochefort et al.
ONCOLOGIST (2019)
Urocortin Induces Phosphorylation of Distinct Residues of Signal Transducer and Activator of Transcription 3 (STAT3) via Different Signaling Pathways
Giovanni Corsetti et al.
MEDICAL SCIENCE MONITOR BASIC RESEARCH (2019)
PI3K: A Crucial Piece in the RAS Signaling Puzzle
Agata Adelajda Krygowska et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Predicting tumour growth and its impact on survival in gemcitabine-treated patients with advanced pancreatic cancer
Maria Garcia-Cremade et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years
Bradley R. Hall et al.
Oncotarget (2018)
Nucleus, Mitochondrion, or Reticulum? STAT3 a La Carte
Lidia Avalle et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Pancreatic Cancer Chemoresistance to Gemcitabine
Manoj Amrutkar et al.
CANCERS (2017)
Sinuleptolide inhibits proliferation of oral cancer Ca9-22 cells involving apoptosis, oxidative stress, and DNA damage
Yung-Ting Chang et al.
ARCHIVES OF ORAL BIOLOGY (2016)
Ovatodiolide of Anisomeles indica Exerts the Anticancer Potential on Pancreatic Cancer Cell Lines through STAT3 and NF-κB Regulation
Ya-Ju Hsieh et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
5-Episinuleptolide Decreases the Expression of the Extracellular Matrix in Early Biofilm Formation of Multi-Drug Resistant Acinetobacter baumannii
Sung-Pin Tseng et al.
MARINE DRUGS (2016)
Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis
Pin Wu et al.
ONCOTARGET (2016)
The history and future of targeting cyclin-dependent kinases in cancer therapy
Uzma Asghar et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
miR-192 Induces G2/M Growth Arrest in Aristolochic Acid Nephropathy
Robert H. Jenkins et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Inefficient degradation of cyclin B1 re-activates the spindle checkpoint right after sister chromatid disjunction
Linda Clijsters et al.
CELL CYCLE (2014)
Cdk1 Inactivation Terminates Mitotic Checkpoint Surveillance and Stabilizes Kinetochore Attachments in Anaphase
Maria Dolores Vazquez-Novelle et al.
CURRENT BIOLOGY (2014)
Antimicrobial Activity of the Marine Alkaloids, Clathrodin and Oroidin, and Their Synthetic Analogues
Nace Zidar et al.
MARINE DRUGS (2014)
Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer
Kolaparthi Venkatasubbarao et al.
MOLECULAR CANCER (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Role of STAT3 in Cancer Metastasis and Translational Advances
Mohammad Zahid Kamran et al.
BIOMED RESEARCH INTERNATIONAL (2013)
5-epi-Sinuleptolide induces cell cycle arrest and apoptosis through tumor necrosis factor/mitochondria-mediated caspase signaling pathway in human skin cancer cells
Chia-Hua Liang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis
Chen Huang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2012)
FOLFIRINOX: a new standard treatment for advanced pancreatic cancer?
Richard Kim
LANCET ONCOLOGY (2011)
Initial steps of metastasis: Cell invasion and endothelial transmigration
Franziska van Zijl et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2011)
Evolution of systemic therapy for advanced pancreatic cancer
Daniel Renouf et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301)
Laetitia Dahan et al.
GUT (2010)
Sinulochmodins A-C, three novel terpenoids from the soft coral Sinularia lochmodes
YJ Tseng et al.
ORGANIC LETTERS (2005)
Five novel norcembranoids from Sinularia leptoclados and S-parva
AF Ahmed et al.
TETRAHEDRON (2003)
Scabrolides A-D, four new norditerpenoids isolated from the soft coral Sinularia scabra
JH Sheu et al.
JOURNAL OF NATURAL PRODUCTS (2002)
Genetic profile of 22 pancreatic carcinoma cell lines -: Analysis of K-ras, p53, p16 and DPC4/Smad4
PS Moore et al.
VIRCHOWS ARCHIV (2001)
Share Paper
